Guggenheim Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Guggenheim Capital’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.65M	Sell	45,309 -1,351	-3%	-$49.1K	0.01%	707
2025 Q1	$1.69M	Buy	46,660 +1,438	+3%	+$52.1K	0.02%	683
2024 Q4	$1.9M	Buy	45,222 +670	+2%	+$28.2K	0.02%	669
2024 Q3	$2.47M	Buy	44,552 +3,956	+10%	+$220K	0.02%	751
2024 Q2	$1.67M	Buy	40,596 +4,701	+13%	+$193K	0.01%	880
2024 Q1	$1.68M	Buy	35,895 +8,186	+30%	+$382K	0.01%	956
2023 Q4	$1.33M	Buy	27,709 +1,952	+8%	+$93.3K	0.01%	1027
2023 Q3	$918K	Buy	25,757 +6,207	+32%	+$221K	0.01%	1141
2023 Q2	$902K	Sell	19,550 -3,654	-16%	-$169K	0.01%	1212
2023 Q1	$930K	Sell	23,204 -7,546	-25%	-$303K	0.01%	1218
2022 Q4	$1.42M	Buy	30,750 +441	+1%	+$20.4K	0.01%	995
2022 Q3	$1.26M	Sell	30,309 -90	-0.3%	-$3.73K	0.01%	1030
2022 Q2	$1.81M	Buy	30,399 +1,415	+5%	+$84.4K	0.01%	927
2022 Q1	$2.1M	Buy	28,984 +1,460	+5%	+$106K	0.01%	994
2021 Q4	$2.32M	Buy	27,524 +2,845	+12%	+$239K	0.01%	986
2021 Q3	$2.23M	Sell	24,679 -109	-0.4%	-$9.83K	0.01%	1001
2021 Q2	$2.36M	Buy	24,788 +2,543	+11%	+$243K	0.01%	1004
2021 Q1	$2.53M	Buy	22,245 +3,866	+21%	+$440K	0.02%	909
2020 Q4	$2.54M	Sell	18,379 -13,486	-42%	-$1.87M	0.02%	865
2020 Q3	$2.62M	Sell	31,865 -9,628	-23%	-$791K	0.02%	778
2020 Q2	$3.25M	Sell	41,493 -7,108	-15%	-$556K	0.03%	688
2020 Q1	$2.16M	Sell	48,601 -9,539	-16%	-$424K	0.02%	757
2019 Q4	$2.48M	Buy	58,140 +10,672	+22%	+$456K	0.02%	952
2019 Q3	$2.03M	Buy	47,468 +3,839	+9%	+$164K	0.02%	1012
2019 Q2	$2.77M	Sell	43,629 -2,296	-5%	-$146K	0.02%	913
2019 Q1	$3.19M	Sell	45,925 -3,476	-7%	-$241K	0.03%	863
2018 Q4	$2.15M	Buy	49,401 +3,676	+8%	+$160K	0.02%	1007
2018 Q3	$3.49M	Sell	45,725 -1,605	-3%	-$123K	0.02%	929
2018 Q2	$3.64M	Sell	47,330 -10,317	-18%	-$793K	0.02%	897
2018 Q1	$2.94M	Buy	57,647 +545	+1%	+$27.8K	0.01%	1367
2017 Q4	$2.65M	Sell	57,102 -11,892	-17%	-$552K	0.01%	1456
2017 Q3	$3.68M	Buy	68,994 +16,589	+32%	+$884K	0.01%	1241
2017 Q2	$3.25M	Buy	52,405 +6,684	+15%	+$415K	0.01%	1272
2017 Q1	$3.1M	Sell	45,721 -1,496	-3%	-$101K	0.01%	1327
2016 Q4	$3.32M	Sell	47,217 -4,960	-10%	-$349K	0.01%	1278
2016 Q3	$3.7M	Sell	52,177 -6,597	-11%	-$468K	0.01%	1200
2016 Q2	$2.88M	Buy	+58,774	New	+$2.88M	0.01%	1324
2016 Q1	–	Sell	-65,713	Closed	-$7.37M	–	2981
2015 Q4	$7.37M	Buy	65,713 +7,622	+13%	+$855K	0.02%	866
2015 Q3	$5.6M	Buy	58,091 +31,932	+122%	+$3.08M	0.02%	975
2015 Q2	$2.68M	Buy	+26,159	New	+$2.68M	0.01%	1551
2014 Q4	–	Sell	-67,043	Closed	-$3.8M	–	3061
2014 Q3	$3.8M	Buy	+67,043	New	+$3.8M	0.01%	1337